CEFICOD-50 – Cefixime Dispersible Tablets IP 50 mg
CEFICOD-50 is a pharmaceutical formulation containing Cefixime 50 mg in dispersible tablet form. Developed as part of the Farlex Pharmaceuticals antibiotic portfolio, this formulation represents an oral solid dosage presentation of a third-generation cephalosporin antibiotic.
Cefixime belongs to the cephalosporin class of antibacterial agents. It works by interfering with bacterial cell wall synthesis, thereby inhibiting bacterial growth. It is used in the management of infections caused by susceptible bacteria, subject to approved indications and clinical assessment.
Composition
Each tablet contains:
Product Specifications
Pharmacological Profile
Cefixime is a third-generation cephalosporin antibiotic with bactericidal activity against susceptible microorganisms. Its antibacterial action involves the inhibition of bacterial cell wall synthesis.
Therapeutic Applications
Cefixime is used for the treatment of certain bacterial infections caused by susceptible organisms. The selection of treatment depends on the infection type, bacterial susceptibility and applicable prescribing guidelines.
Formulation Features
-
Cefixime-based antibacterial formulation.
-
50 mg strength.
-
Dispersible tablet dosage form.
-
Oral administration.
-
Presented in a 10 × 10 tablet pack.
Important Information
CEFICOD-50 is a prescription antibiotic formulation. It should be used only under the direction of a qualified medical practitioner. Antibiotic selection and treatment duration must follow the approved prescribing information and applicable antimicrobial stewardship guidelines.
Antibiotics are not effective against viral infections.